What are the side effects
Semaglutide is a non-surgical alternative that can be considered for individuals who prefer a non-invasive approach or who do not meet the criteria for surgical interventions like a gastric sleeve
In early clinical trials, patients on GLP-1 agonists have achieved weight loss of 1520%, compared to the 510% typically seen with previous medications. Holistic approach to GLP-1 drugs Beyond weight loss, GLP-1 agonists have demonstrated the ability to reduce major cardiovascular events, combat fatty liver disease and alleviate obesity-related complications such as knee pain, sleep apnea, and acid reflux
At the pancreas, it potentiates glucose-stimulated insulin secretion while suppressing glucagon release, thereby lowering circulating glucose concentrations
rare cases of intestinal obstruction have been reported Pregnancy and lactation : GLP-1 agonists are not recommended during pregnancy or breastfeeding
Administering Tirzepatide: Dosage and Technique Administered as a once-weekly subcutaneous injection, tirzepatide offers a practical routine
